Literature DB >> 10933317

A comparison of microbiologic flora of the sinuses and airway among cystic fibrosis patients with maxillary antrostomies.

A Dosanjh1, S Lakhani, D Elashoff, C Chin, V Hsu, B Hilman.   

Abstract

The placement of maxillary antrostomies among cystic fibrosis (CF) patients has been used as a treatment to allow localized antibiotic lavage of infected sinus passages. This procedure is increasingly recommended by lung transplantation centers as a prerequisite prior to accepting a CF patient as a candidate for transplantation. Our study attempts to define the degree of identity between sinus, endotracheal and sputum cultures from 35 patients. The samples (n = 137) were collected within two weeks of each other. An analysis of the microbiologic type, strain, and antibiotic resistance patterns was undertaken. Randomization analysis was performed and a p-value of < 0.05 was considered significant. The results indicated a high degree of correlation between sinus-sputum pairs (n = 55) and endotracheal samples (p < 0.008). This study provides evidence that there is a potential for cross-infection between sinus passages and the lower airway. The localized irrigation of CF sinus cavities post-transplantation may be warranted in an attempt to reduce bacterial counts and potential direct infection of the allograft. However, it is unlikely that this will eliminate this risk because bacterial colonization continues and the CF trachea is another source of infection.

Entities:  

Mesh:

Year:  2000        PMID: 10933317     DOI: 10.1034/j.1399-3046.2000.00114.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  10 in total

1.  Posttransplant sinus surgery in lung transplant recipients with cystic fibrosis: a single institutional experience.

Authors:  Domenic Vital; Markus Hofer; Annette Boehler; David Holzmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-03-30       Impact factor: 2.503

Review 2.  Management of the upper airway in cystic fibrosis.

Authors:  Elisa A Illing; Bradford A Woodworth
Journal:  Curr Opin Pulm Med       Date:  2014-11       Impact factor: 3.155

3.  Clinical predictors of cystic fibrosis chronic rhinosinusitis severity.

Authors:  Anna C Zemke; Seyed Mehdi Nouraie; John Moore; Jordan R Gaston; Nicholas R Rowan; Joseph M Pilewski; Jennifer M Bomberger; Stella E Lee
Journal:  Int Forum Allergy Rhinol       Date:  2019-06-04       Impact factor: 3.858

4.  Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection.

Authors:  Susse Kirkelund Hansen; Martin Holm Rau; Helle Krogh Johansen; Oana Ciofu; Lars Jelsbak; Lei Yang; Anders Folkesson; Hanne Østergaard Jarmer; Kasper Aanæs; Christian von Buchwald; Niels Høiby; Søren Molin
Journal:  ISME J       Date:  2011-06-30       Impact factor: 10.302

Review 5.  New insights into the pathogenesis of cystic fibrosis sinusitis.

Authors:  Eugene H Chang
Journal:  Int Forum Allergy Rhinol       Date:  2013-11-26       Impact factor: 3.858

6.  Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients.

Authors:  Renan Marrichi Mauch; Claudio Lucio Rossi; Marcos Tadeu Nolasco da Silva; Talita Bianchi Aiello; José Dirceu Ribeiro; Antônio Fernando Ribeiro; Niels Høiby; Carlos Emilio Levy
Journal:  Med Microbiol Immunol       Date:  2019-01-31       Impact factor: 3.402

7.  T2R38 genotype is correlated with sinonasal quality of life in homozygous ΔF508 cystic fibrosis patients.

Authors:  Nithin D Adappa; Alan D Workman; Denis Hadjiliadis; Daniel J Dorgan; Danielle Frame; Steven Brooks; Laurel Doghramji; James N Palmer; Corrine Mansfield; Danielle R Reed; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2015-12-17       Impact factor: 3.858

8.  Medical and Surgical Advancements in the Management of Cystic Fibrosis Chronic Rhinosinusitis.

Authors:  Kiranya E Tipirneni; Bradford A Woodworth
Journal:  Curr Otorhinolaryngol Rep       Date:  2017-02-21

Review 9.  Inhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches.

Authors:  Sylvia Natalie Kłodzińska; Petra Alexandra Priemel; Thomas Rades; Hanne Mørck Nielsen
Journal:  Int J Mol Sci       Date:  2016-10-09       Impact factor: 5.923

10.  A case of failed eradication of cystic fibrosis-related sinus colonisation by Pseudomonas aeruginosa.

Authors:  Barry Linnane; Linda Kearse; Nuala H O'Connell; John Fenton; Miranda G Kiernan; Colum P Dunne
Journal:  BMC Pulm Med       Date:  2015-10-06       Impact factor: 3.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.